what are some of the challenges developing and manufacturing bi- and multi-specific antibodies?
Published 1 year ago • 132 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
0:36
flexible manufacturing solutions at right scale
-
4:42
mrna - a new option for vaccines and therapeutics
-
3:02
introducing catalent xpress pharmaceutics™ - facilitate adaptive trials and accelerate phase 1
-
5:02
cdmo perspective on partnering with clients from phase i through commercialization
-
0:29
biosimilars | why catalent?
-
0:59
why choose catalent to launch your next consumer health product?
-
0:35
catalent: a true strategic partner
-
2:05
take your biologic to clinic or market, faster
-
1:52
optishell technology solves bioavailability challenges | catalent in 90 seconds
-
3:46
catalent corporate overview
-
16:32
new antibodies and antibody-drug conjugates for b-cell lymphoma
-
6:24
how important are lab findings?
-
1:29
what is the expert answers video series?
-
2:15
life science test expertise - better health from head to toe
-
1:05
factors to consider when choosing a cdmo for late-stage biologics programs
-
2:04
challenges of healthcare keeping up with technology
-
8:34
multiple myeloma: challenges in diagnosis and role of multidisciplinary care
-
35:46
nanomaterials -- the possibilities and challenges
-
4:26
nottingham, uk - 360⁰ video tour